NextGen Omics US
In-Person Conference
The NextGen Omics US brings together leading omics experts from around the world.
Delegates can expect to benefit from discussions in the future of Next Generation Sequencing, Multi-omic Single Cell Analysis and Genome editing in Drug Discovery and Therapeutic Development.
Date:
Wednesday, March 30, 09:20 - 09:50 am (EDT)
Title:
CRISPR cell line development revolutionized:
Combining the power of CRISPR with FluidFM® to provide engineered cell lines as a service
Abstract:
Sensitive cells? Complex edits? High quality needed? We create the cell line for you.
Cytosurge provides you guaranteed monoclonal cell lines with high quality – even for hard-to-transfect and rare cells, complex edits like knock-in with large repair templates, or multiple knock-outs.
During the presentation of Dr. Tobias Beyer, our Chief Scientific Officer, you will learn more about our service enabled by our proprietary FluidFM® technology:
What is FluidFM and how can it be applied to cell line engineering
True single cell genome engineering: the power of the bottom-up approach
High quality monoclonal cell lines by reducing off-target editing and avoiding the tedious selection process
Customized design and consulting by our experts
Recent customer projects